Gain Therapeutics logo

Gain Therapeutics

GANX | NASDAQ
Chart Builder DCF Calculator
$0.94
-$0.10 (-9.62%)
At close: Nov 16, 2026, 4:00 PM ET
$1.10
+$0.16 (+17.02%)
After-hours: Nov 16, 2026, 6:40 PM ET
-9.62%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
38.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #575/1021 (Top 56%)

Key Statistics

Market Data

Market Cap $40.1M
1D Range
0.94 1.08
52W Range
0.94 4.18

Valuation (TTM)

PE -2.24
PB 3.95
EV/EBITDA -1.66

Valuation (NTM)

Forward PE N/A
Forward PEG 0.07
Price Target $5.00
Loading financial charts...

Profile

Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its effort...

Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Mar 19, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$5.00
Upside
+431.91%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.